The National Board of Revenue has extended the duty benefit on import of 17 types of products, including personal protective equipments and its raw materials, required to fight the coronavirus outbreak till December 31 to ensure availability of the items amid the outbreak.
The NBR’s customs wing issued a statutory regulatory order on October 5 extending the benefit as the tenure of the previous order on the exemption expired on September 30.
The benefit, including exemption from payment of customs duty, regulatory duty, supplementary duty, value-added tax, advance tax and advance income tax on import of the products, would be applicable with retrospective effect from October 1, according to the SRO.
It said that only industrial IRC holding pharmaceutical industry, medical instrument manufacturers and garment manufacturers would be allowed to import the raw materials to produce PPEs, disinfectants and masks following the approval of the Director General of Drug Administration.
Commercial importers will also enjoy the benefits on import of a number of products.
The products include COVID-19 test kits based on immunological reactions, disinfectants in bulk, COVID-19 test kits based on polymerase chain reaction nucleic acid tests, protective garments made from plastic sheeting, plastic face shields, N95 masks, KN95 masks, protective spectacles and goggles, other breathing appliances and gas masks and COVID-19 diagnostic test instruments and apparatuses.
The raw materials include isopropyl alcohol, felt of textile materials, different types of non-woven man-made filaments and other fabrics impregnated with polyvinyl chloride, ear bands for masks and nose protector clip masks.
According to the SRO, the DGDA will regularly determine the quantity of items to be imported by the importers and regularly monitor the quality of imported goods.
The DGDA will also submit a report containing data on the quantity of products imported under the benefit and names of the importers after the deadline of the SRO expires, it said.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Tax